| Index | — | P/E | 22.20 | EPS (ttm) | 1.96 | Insider Own | 0.42% | Shs Outstand | 283.63M | Perf Week | 0.95% |
| Market Cap | 12.34B | Forward P/E | 18.44 | EPS next Y | 2.36 | Insider Trans | -0.24% | Shs Float | 282.84M | Perf Month | 12.54% |
| Enterprise Value | 20.86B | PEG | 4.23 | EPS next Q | 0.34 | Short Float | 2.63% | Perf Quarter | 12.22% | ||
| Income | 555.00M | P/S | 4.80 | EPS this Y | 4.50% | Short Ratio | 3.22 | Perf Half Y | 14.44% | ||
| Sales | 2.57B | P/B | 1.76 | EPS next Y | 5.63% | ROA | 2.78% | Short Interest | 7.43M | Perf YTD | 13.45% |
| Book/sh | 24.74 | P/C | — | EPS next 5Y | 5.25% | ROE | 8.05% | 52W High | 44.09 -1.29% | Perf Year | 11.11% |
| Cash/sh | 0.03 | P/FCF | — | EPS past 3/5Y | 7.52% 14.46% | ROIC | 4.40% | 52W Low | 36.10 20.55% | Perf 3Y | 31.80% |
| Dividend Est. | 1.44 (3.31%) | EV/EBITDA | 15.37 | Sales past 3/5Y | 2.65% 11.09% | Gross Margin | 53.48% | Volatility | 1.94% 2.04% | Perf 5Y | -7.25% |
| Dividend TTM | 1.39 (3.19%) | EV/Sales | 8.12 | EPS Y/Y TTM | -15.88% | Oper. Margin | 35.06% | ATR (14) | 0.89 | Perf 10Y | 46.98% |
| Dividend Ex-Date | Nov 10, 2026 | Quick Ratio | 0.62 | Sales Y/Y TTM | 9.88% | Profit Margin | 21.60% | RSI (14) | 68.71 | Recom | 2.50 |
| Dividend Gr. 3/5Y | 6.36% 6.62% | Current Ratio | 0.78 | EPS Q/Q | 0.00% | SMA20 | 6.72% | Beta | 0.60 | Target Price | 44.50 |
| Payout | 69.80% | Debt/Eq | 1.21 | Sales Q/Q | 3.11% | SMA50 | 6.80% | Rel Volume | 1.01 | Prev Close | 42.78 |
| Employees | 3,303 | LT Debt/Eq | 1.20 | Earnings | Nov 03 | SMA200 | 10.44% | Avg Volume | 2.28M | Price | 43.52 |
| IPO Date | Mar 17, 1980 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 2.36% -1.49% | Net Debt/EBITDA | 6.27 | Volume | 2,301,119 | Change | 1.73% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-10-26 | Reiterated | UBS | Buy | $46 → $49 |
| Jul-15-26 | Reiterated | Barclays | Underweight | $38 → $40 |
| Jul-02-26 | Reiterated | UBS | Buy | $43 → $46 |
| May-29-26 | Upgrade | UBS | Neutral → Buy | $41 → $43 |
| May-07-26 | Reiterated | UBS | Neutral | $45 → $41 |
| Dec-17-25 | Downgrade | Barclays | Overweight → Underweight | $43 → $38 |
| Dec-03-25 | Reiterated | Northcoast Research | Buy | $46 → $42 |
| Oct-28-25 | Downgrade | UBS | Buy → Neutral | $47 → $45 |
| Oct-28-25 | Downgrade | Jefferies | Buy → Hold | $44 |
| Oct-27-25 | Reiterated | Northcoast Research | Buy | $46 |
Essential Utilities, Inc. is a diversified utility enterprise that, through its various operating units, delivers vital water, wastewater, and natural gas services within the United States. Its operations extend beyond direct utility provision, encompassing contractual management and maintenance of water systems for municipal authorities and other organizations. The company also offers specialized non-utility services, such as providing untreated water resources for the natural gas drilling sector and, via a third-party partner, supplying protective and repair solutions for household water and sewer lines. Catering to an extensive client base of approximately 7.5 million residential, commercial, industrial, fire protection, and general utility customers, Essential Utilities operates under the well-known Aqua and Peoples brands across a significant geographic footprint. This footprint includes Pennsylvania, Ohio, Texas, Illinois, North Carolina, New Jersey, Indiana, Virginia, West Virginia, and Kentucky. Founded in 1886, the corporation is headquartered in Bryn Mawr, Pennsylvania, and adopted its current name, Essential Utilities, Inc., in February 2020, previously being known as Aqua America, Inc.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,569 | 2,475 | 2,086 | 2,054 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,195 | 1,461 | 864 | 928 | — | — | — | — | — | |
| Gross Profit | 1,374 | 1,014 | 1,222 | 1,126 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 154 | 0 | 0 | 0 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 319 | 93 | 464 | 434 | — | — | — | — | — | |
| Operating Income | 901 | 921 | 758 | 692 | — | — | — | — | — | |
| Interest Expense | 343 | 329 | 302 | 283 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 27 | 28 | 118 | 23 | — | — | — | — | — | |
| Net Income Before Taxes | 584 | 620 | 573 | 432 | — | — | — | — | — | |
| Income Taxes | 28 | 3 | -22 | -66 | — | — | — | — | — | |
| Consolidated Net Income | 555 | 616 | 595 | 498 | — | — | — | — | — | |
| Net Income From Continuing Operations | 555 | 616 | 595 | 498 | — | — | — | — | — | |
| Net Income | 555 | 616 | 595 | 498 | — | — | — | — | — | |
| EPS (Recurring) | 1.96 | 2.20 | 2.17 | 1.86 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.96 | 2.20 | 2.17 | 1.86 | — | — | — | — | — | |
| EPS (Diluted) | 1.96 | 2.20 | 2.17 | 1.86 | — | — | — | — | — | |
| EBITDA | 1,357 | 1,366 | 1,245 | 1,059 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 22.20 | 17.44 | 16.74 | 20.08 | — | — | — | — | — | |
| Price To Sales Ratio | 4.81 | 4.34 | 4.77 | 4.86 | — | — | — | — | — | |
| Gross Margin | 53.48 | 40.97 | 58.58 | 54.82 | — | — | — | — | — | |
| Operating Margin | 35.07 | 37.21 | 36.34 | 33.69 | — | — | — | — | — | |
| Net Margin | 21.60 | 24.89 | 28.52 | 24.25 | — | — | — | — | — | |
| Shares Outstanding | 284 | 280 | 274 | 267 | — | — | — | — | — | |
| Market Capitalization | 12,360 | 10,741 | 9,952 | 9,972 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Arnold Colleen | President - Aqua | Aug 07 '26 | Sale | 39.55 | 2,855 | 112,915 | 17,347 | Aug 11 |
| Franklin Chris | Chief Executive Officer | Mar 14 '25 | Sale | 39.40 | 7,700 | 303,380 | 32,229 | Mar 17 |
| RUBIN ROBERT A | Chief Accounting Officer | Jul 01 '24 | Sale | 37.43 | 2,342 | 87,661 | 53,391 | Jul 02 |
| RUBIN ROBERT A | Chief Accounting Officer | May 01 '24 | Sale | 36.56 | 4,046 | 147,922 | 13,358 | May 06 |
| RUBIN ROBERT A | Chief Accounting Officer | Apr 01 '24 | Sale | 37.21 | 5,565 | 207,074 | 57,756 | Apr 02 |
| RUBIN ROBERT A | Chief Accounting Officer | Mar 11 '24 | Sale | 36.00 | 3,551 | 127,836 | 63,321 | Mar 13 |
| RUBIN ROBERT A | Chief Accounting Officer | Mar 05 '24 | Sale | 35.60 | 6,350 | 226,060 | 66,872 | Mar 07 |
| Amato Elizabeth B | Director | Mar 05 '24 | Buy | 35.02 | 3,100 | 108,559 | 16,103 | Mar 07 |
| Arnold Colleen | President | Jun 14 '23 | Sale | 41.84 | 1,244 | 52,049 | 7,796 | Jun 15 |
| Franklin Chris | Chief Executive Officer | Mar 08 '23 | Buy | 40.70 | 37,245 | 1,515,872 | 37,245 | Mar 09 |
| Ruff Ellen T | Director | Nov 28 '22 | Sale | 47.96 | 8,560 | 410,503 | 26,972 | Nov 29 |
| RUBIN ROBERT A | Chief Accounting Officer | Dec 08 '21 | Sale | 51.00 | 1,954 | 99,654 | 69,871 | Dec 09 |
| SCHULLER DANIEL | Executive Vice President | Aug 30 '21 | Sale | 50.00 | 2,000 | 100,000 | 41,684 | Sep 01 |
| Franklin Chris | Chief Executive Officer | Aug 05 '21 | Option Exercise | 32.04 | 44,183 | 1,415,461 | 219,885 | Aug 09 |
| Franklin Chris | Chief Executive Officer | Aug 05 '21 | Sale | 50.00 | 132,549 | 6,627,450 | 131,519 | Aug 09 |